<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0215">
 <label>43</label>
 <element-citation publication-type="journal" id="sbref0215">
  <person-group person-group-type="author">
   <name>
    <surname>Aricò</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Monque</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>D’Agostino</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Moschella</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Venditti</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kalinke</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Allen</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Nash</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Belardelli</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Ferrantini</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68</article-title>
  <source>Vaccine.</source>
  <volume>29</volume>
  <year>2011</year>
  <fpage>3935</fpage>
  <lpage>3944</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2011.03.092</pub-id>
  <pub-id pub-id-type="pmid">21481326</pub-id>
 </element-citation>
</ref>
